v3.26.1
Collaboration Agreements - Narrative (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Accounts receivable, net $ 182,183 $ 187,802
Biogen Collaboration Agreement    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Accounts receivable, net 15,700 $ 23,000
Shionogi | License    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Contract liabilities 90,000  
Revenue, remaining performance obligation, variable consideration amount 470,000  
Shionogi | License | Achievement Of Specified Regulatory Milestones    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Revenue, remaining performance obligation, variable consideration amount 40,000  
Shionogi | License | Achievement Of Specified Commercialization Milestones    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Revenue, remaining performance obligation, variable consideration amount 10,000  
Shionogi | License | Achievement Of Specified Net Sales Milestones    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Revenue, remaining performance obligation, variable consideration amount $ 385,000